Dexamethasone Implant With Anti-VEGF Explored for Wet AMD

Source: Medscape

Friday, February 03, 2017 | Medical Studies , Retina , AMD


Used in combination with antivascular endothelial growth factor (anti-VEGF) therapy, dexamethasone implants (0.7 mg Ozurdex, Allergan) may help some patients with neovascular age-related macular degeneration (nAMD) that is resistant to anti-VEGF monotherapy, researchers say. In a group of patients with a disappointing response to anti-VEGF treatment, the implants improved anatomical signs of disease, reduced the number of injections needed, and showed a trend toward improved visual acuity, say Bozho Todorich, MD, PhD, from Associated Retinal Consultants in Royal Oak, Michigan, and colleagues.

Open in New Window

Comments

You must be logged in to leave a comment.